Cancer vaccine targets leukemia

Nature Medicine

Volumn 9, Issue 11, 2003, Pages 1354-1356

  Donnelly, John ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CYTOKINE; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

BIOLOGICAL MODEL; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; DRUG SCREENING; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SHORT SURVEY; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CANCER VACCINES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; TRETINOIN;

MUS MUSCULUS;

EID: 0345276639     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1103-1354     Document Type: Short Survey

References (11)

1. Fisher, R.I., Rosenberg, S.A., Sznol, M., Parkinson, D.R. & Fyfe, G. Cancer J. Sci. Am. 3, 568-569 (1997).
2. Padua, R.A. et al. Nat. Med. 9, 1413-1417 (2003).
3. Small, E.J. et al. J. Clin. Oncol. 18, 3894-3903 (2000).
4. Dummer, R. Curr. Opin. Invest. Drugs 2, 844-888 (2001).
5. Belli, F. et al. J. Clin. Oncol. 20, 4169-4180 (2002).
6. Su, Z. et al. Cancer Res. 63, 2127-2133 (2003).
7. O'Rourke, M.G. et al. Cancer Immunol. Immunother. 52, 387-395 (2003).
8. Peterson, A.C., Harlin, H. & Gajewski, T.F. J. Clin. Oncol 21, 2342-2348 (2003).
9. Sheets, E.E. et al, Am. J. Obstet. Gynecol. 188, 916-926 (2003).
10. Park, D.J., Vuong, P.T., DeVos, S., Douer, D. & Koeffler, H.P. Blood, published online 31 July 2003 (doi: 10.1182/blood-2003-02-0412).
11. Westervelt, P. et al. Proc. Natl. Acad. Sci. USA 99, 9468-9473 (2002).